A New Alpha-Immunotherapy
Hope for Bladder Cancer Using Astatine-211
Hope for Bladder Cancer Using Astatine-211
Chelatec will attend Bio-Europe Spring 2025 in Milan.
Chelatec will attend the TRP – Target Selection and Drug Design Summit
Chelatec will be exhibiting at the SNMMI Annual Meeting
Chelatec will be attending Bio’s largest partnering event.
Chelatec will attend Bio-Europe Spring 2024 in Barcelona.